FDA-approved Drug Listings

FDA, Ozempic and Wegovy

Ozempic and Wegovy officially moved off FDA’s drug shortage list

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration’s (FDA) drug shortage list nearly four months after the agency found the drugs to be available.

USA TODAY on MSN · 22h

Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage list

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug is no longer on the FDA shortage list.

CNN on MSN · 1d

Ozempic and Wegovy are no longer in shortage, FDA says

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

Mirum, FDA and drug

Reuters · 22h

US FDA approves Mirum Pharma's genetic disorder drug

The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first treatment for a rare condition that interferes with the body's ability to process cholesterol.

Medical Xpress on MSN · 4d

FDA-approved osteoporosis drug may treat rare genetic heart disease

A research team co-led by scientists at the University of Arizona College of Medicine – Tucson found that an osteoporosis drug might counter a rare genetic mutation underlying a type of heart disease.

Business Insider · 1d

FDA approves Mirum treatment for cerebrotendinous xanthomatosis

The Food and Drug Administration approved Ctexli for the treatment of cerebrotendinous xanthomatosis in adults. “Ctexli is the first

JD Supra1d

FDA Approved Journavx, a Non-Opioid Drug for Pain Management

On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...

BioSpace1d

Coalition Urges FDA to Act as Report Finds Illegal GLP-1 Ingredients ‘Flooding’ Into US

Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, according to a new analysis.

Fierce Healthcare22h

FDA declares semaglutide shortage over, spelling end to compounded GLP-1 market

The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...

Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq

The closing of the business combination with PowerUp Acquisition Corp. creates Nasdaq-listed biopharmaceutical company dedicated to developing breakthrough innovations in FDA approved drugs, ...

US FDA approves GSK's combo meningococcal vaccine

The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results